Similar articles

• Comments on 'maintaining confidentiality of interim data to enhance trial integrity and credibility' by TR Fleming et al.

  Korn EL, Hunsberger S, Freidlin B, Smith MA, Abrams JS. Korn EL, et al. Clin Trials. 2008;5(4):364-5; author reply 365-6. doi: 10.1177/1740774508094749. Clin Trials. 2008. PMID: 18697851 No abstract available.
• Comments about the prospective randomized trial by Aoyama et al.

  Patchell RA, Regine WF, Renschler M, Loeffler JS, Sawaya R, Chin LS, Andrews DW. Patchell RA, et al. Surg Neurol. 2006 Nov;66(5):459-60. doi: 10.1016/j.surneu.2006.08.003. Surg Neurol. 2006. PMID: 17084184 No abstract available.
• Dropouts and missing data in psychiatric clinical trials.

  Potkin SG, Siu CO. Potkin SG, et al. Am J Psychiatry. 2009 Nov;166(11):1295; author reply 1295-6. doi: 10.1176/appi.ajp.2009.09070959. Am J Psychiatry. 2009. PMID: 19884237 No abstract available.
• Randomized controlled trials as evidence in legal disputes about the benefits of complementary and alternative medicine.

  Coulter ID, Walsh J. Coulter ID, et al. Altern Ther Health Med. 2008 Mar-Apr;14(2):60-4. Altern Ther Health Med. 2008. PMID: 18383991 Review. No abstract available.
• Methodological quality of patient-reported outcome research was low in complementary and alternative medicine in oncology.

  Efficace F, Horneber M, Lejeune S, Van Dam F, Leering S, Rottmann M, Aaronson NK. Efficace F, et al. J Clin Epidemiol. 2006 Dec;59(12):1257-65. doi: 10.1016/j.jclinepi.2006.03.006. Epub 2006 Jul 3. J Clin Epidemiol. 2006. PMID: 17098568 Review.